Research from Professor Lynn Blewett found the cost of a national reinsurance program can range from $5.3 billion to $15.7 billion per year based on varying coverage limits and payment rates.
A study by researcher Stuart Grande shows mHealth apps, such as Genia, help children with Juvenile Idiopathic Arthritis share their needs and experiences with their families and care teams.
Assistant Professor David Vock has been named a McKnight Presidential Fellow, a three-year award given to promising faculty members based on their research, scholarship, leadership, and ability to advance University of Minnesota priorities.
Findings from a study by postdoctoral researcher Mary Christoph show that dietary intake of vegetables and whole grains is improving as youth age into young adults.
Associate Professor Pamela Lutsey found that DOAC drugs appear to be just as safe to use as heparin and warfarin for treating venous thromboembolism in cancer patients.
Research co-led by Professor Cavan Reilly shows Ebola survivors suffer from a range of health problems including body pain, eye conditions, and memory loss.
Each year, teams from across the U.S. and Canada come together for the University of Alabama at Birmingham (UAB) Health Administration Case Competition. For the second year in a row, the team from the University of Minnesota School of Public Health MHA program took first place.
Research from recent doctoral graduate Xarviera Appling (PhD ’18) studied the effect of food safety management practices on inspection risk factor violations in 546 routine restaurant inspections.
The study, co-authored by Associate Professor Ezra Golberstein and led by SPH graduate and University of Pittsburgh Assistant Professor Coleman Drake (PhD ’18), evaluated the influence of the Mental Health Parity and Addiction Equity Act (MHPAEA) of 2008 on the use of outpatient and clinic-based mental health services and spending.
The method developed by Assistant Professor Silvia Balbo may help researchers uncover the genetic chemistry leading to cancer development, which has broad applications ranging from understanding how toxins are affecting DNA in the body to developing tools to improve outcomes of chemotherapy.